KC mice treated with CCG-222740 showed a significant upregulation in the percentage of CD4 T cells (CD45+, CD3+, CD4+) infiltrating into the pancreas (p = 0.03), 21.6% in the control vs. 27.4% in the treated group (Fig. 5A). This evidence concerns the gene CD4 and keratoconus.